Summarized by Masters of Longevity from PR Newswire.
PharmaLogic agreed to buy Lantheus' CDMO business and New Jersey facility.
Key Takeaways
- PharmaLogic was reported to acquire Lantheus' CDMO business.
- The deal was reported to include Lu‑177 dotatate supply agreement.
- The acquisition was reported to create a transatlantic CDMO platform.
